Vectura News

Discover more about our company, science, innovation and people with the latest headlines from Vectura.

Displaying 12 of 65

Will Downie named in The Medicine Maker’s Power List for 2021

Published15/04/2021

Read more
Vectura Group publishes 2020 preliminary results

Published18/03/2021

Read more
Vectura Expands Dry Powder Inhaler Development and Manufacturing Capabilities at its Facility in Chippenham, U.K.

Published05/03/2021

Read more
Vectura Virtual Audits

Published26/02/2021

Read more
Pre-close trading update confirms 2020 trading ahead of expectations

Published12/01/2021

Read more
Vectura Group appoints Jeanne Hecht and Jeanne Thoma to its Board of Directors

Published30/12/2020

Read more
Vectura provides update on GSK litigation

Published29/12/2020

Read more
Vectura earns $11m milestone as Hikma receives US FDA approval for generic Advair Diskus®

Published17/12/2020

Read more
Vectura Expands Capabilities to Handle and Develop Highly Potent Inhaled Drugs at its Facility in Chippenham, U.K.

Published14/12/2020

Read more
Vectura signs agreement with Kinaset Therapeutics Inc. to support the development of VR588 to treat asthma

Published30/11/2020

Read more
Vectura provides update on GSK litigation

Published19/11/2020

Read more
Will Downie’s podcast: “There’s a patient at the end of every piece of work we do…”

Published08/10/2020

Read more

Displaying 12 of 65